NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.

Biotechnology

NRx Pharmaceuticals

NRx Pharmaceuticals' headquarters in Wilmington, DE, United States

Dennis K. McBride

Matthew Duffy

Rick Panicucci

Jonathan C. Javitt

Philip T. Lavin

Martin Brecher

M. Daniel Gordin

Zachary Javitt

Chaim Hurvitz

Patrick Flynn

Harry B. Peled

Wayne Pines

Sherry A. Glied

Daniel C. Javitt

Andrew Nierenberg

Marion Leboyer

Aaron Gorovitz

Melvin L. Morganroth

The Business Development and Strategy team at NRx Pharmaceuticals is responsible for identifying growth opportunities, forming strategic partnerships, and driving the commercialization of innovative therapies like ZYESAMI and NRX-101. This multidisciplinary team leverages their expertise in science, finance, and marketing to develop and execute strategies that enhance the company’s market position and ensure the successful delivery of life-saving treatments to patients.

Business Development and Strategy

The Leadership Team at NRx Pharmaceuticals is responsible for guiding the company's strategic direction and overseeing the development of innovative treatments for critical health challenges. This team, composed of industry experts in science, finance, and strategy, collaborates to drive research initiatives, ensure regulatory compliance, and secure funding while fostering partnerships that advance the clinical-stage development of ZYESAMI and NRX-101. Their collective expertise shapes the vision and operational priorities of NRx as it seeks to make a meaningful impact in the pharmaceutical landscape.

Leadership Team

The Medical and Regulatory Affairs team at NRx Pharmaceuticals is responsible for ensuring the scientific integrity and regulatory compliance of clinical programs. They provide strategic guidance on clinical development and regulatory submissions for key products like ZYESAMI and NRX-101, while advocating for patient needs and liaising with health authorities to facilitate the approval process and ensure safe and effective treatments.

Medical and Regulatory Affairs

��

NRx Pharmaceuticals

Org chart

Board & advisors

Teams

Business Development and Strategy

Leadership Team

Medical and Regulatory Affairs

Offices

��������

NRx Pharmaceuticals

Org chart

Board & advisors

Teams

Business Development and Strategy

Leadership Team

Medical and Regulatory Affairs

Offices

Related companies

��